Status:
TERMINATED
Insulin Infusion Diabetes Ulcer
Lead Sponsor:
Karolinska Institutet
Conditions:
Diabetes Mellitus
Insulin Resistance
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Normoglycemia is important for the outcome of surgical and medical conditions. Insulin infusions have been studied to achieve normoglycemia during these circumstances and have proved to be useful. Ins...
Detailed Description
Introduction: Normoglycemia is important for the outcome of acute surgical and medical conditions. Different insulin infusions have been studied to achieve normoglycemia and have proved to be useful....
Eligibility Criteria
Inclusion
- Patients are eligible for inclusion if the following criteria are fulfilled:
- Patients with diabetes type 1 or type 2.
- Older than 18 years.
- Patients scheduled for cardio- vascular surgery and/ or acute ulcer infection.
- Hyperglycaemia: Capillary P-glucose above 8 mmol/L.
- Informed consent obtained.
Exclusion
- Patients having any of the following at randomization will not be included in the study:
- Unconsciousness: not possible to wake up.
- Ketoacidosis: pH less or equal to 7.30.
- Hyperosmolar syndrome: S-Na more or equal to 150 mmol/L.
- Kidney failure: calculated GFR \< 30 mL/min.
- Pregnancy.
- Mental condition making the subject unable to understand the concepts and risk of the study
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00700154
Start Date
November 1 2011
End Date
December 21 2020
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Vascular Surgery, Karolinska University Hospital
Stockholm, Sweden, SE-171 76